Most patients who have spinal cord stimulators (SCS) implanted for chronic pain have long standing and complex pain concerns. In addition to the index pain being targeted for SCS, often there are psychological co-morbidities, physical deconditioning, ongoing opioid pain medication use, and secondary pain problems. In order to truly optimize the desired outcomes for these patients, each of these areas need to be addressed. This session will focus on the latest medical, behavioral, and regenerative medicine approaches to help optimize neuromodulation outcomes.
Upon completion of this educational activity, participants should be able to:
- Demonstrate the effects of long-term opioid use on SCS outcomes and discuss pragmatic opioid tapering strategies that can be incorporated into clinical practice.
- Explain how psychological and behavioral factors impact the outcomes of SCS for pain.
- Discuss how advances in neurobiology have led emerging treatments for neuropathic pain.
- Describe the latest scientific and clinical evidence for regenerative and gene therapies for patients with chronic pain.
Impact of Opioids on Spinal Cord Stimulation Outcomes and a Practical Approach to Taper After Implant
W. Michael Hooten, MD
Impact of Psychological Factors on Spinal Cord Stimulation Outcomes
Ajay D. Wasan, MD MSc
Emerging Pharmacologic Therapies in Pain
Charles E. Argoff, MD
Emerging Regenerative Medicine and Gene Therapy Treatments in Pain
Jianguo Cheng, MD PhD
Faculty and Presentations subject to change.
- Neuromodulation for Advanced Implantable Therapies: A Hands-On Cadaver Course for Pain Fellows
- Certificate of Attendance: Advanced Neuraxial Neuromodulation
- Controversies in Intrathecal Therapy
- Thematic Abstract Presentations
- Plenary Session I -- What We Have Learned About Placebo: Implications for Clinical Practice and the Interpretation of Evidence About Analgesics